Fig. 11From: Management of retinitis pigmentosa by Wharton’s jelly derived mesenchymal stem cells: preliminary clinical resultsDissapear of lipofuscin deposits after the WJ-MSC application (Table 1, patient no.26: left eye)Back to article page